Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Inherent›
Products & Services
Self-Improving AI Research Lab

Inherent› offers Self-Improving AI Research Lab

ProductCurrently Offered

AI platform combining human research with self-improving AI for scientific discovery.

Loading
Overview

Inherent — Recursively self-improving to discover new knowledge is the AI platform developed by Inherent, designed to accelerate research across domains and power next-generation autonomous labs. It enables a new kind of collective intelligence that leverages the comparative advantages of humans and machines.

The platform is built on the principle of recursive collective self-improvement, applying AI to advance research discussions, resource allocation, hardware infrastructure, training data, and learning algorithms within an organisation designed from scratch around recursive loops.

Self-Improving AI Research Lab - Classification

Industry
  • Artificial Intelligence
Model
  • AI Platform

Self-Improving AI Research Lab - Direct Competitors

  • Isomorphic Labs

    Isomorphic Labs logo

    Drug Design Engine

    isomorphiclabs.com

  • FutureHouse

    FutureHouse logo

    FutureHouse

    futurehouse.org

AttributeSelf-Improving AI Research LabDrug Design EngineFutureHouse
ProviderInherentinherentlabs.ai$50M raised · SeedIsomorphic Labsisomorphiclabs.com$2.8B raised · Series BFutureHousefuturehouse.org
Founded202620212023
Sells ToR&D TeamsEnterprise—
Pricing ModelPre-RevenueLicensing—
OwnershipPublic Benefit CorporationVenture-backed private company—
Self-Improving AI Research Lab

Provider Inherentinherentlabs.ai$50M raised · Seed

Founded 2026

Sells To R&D Teams

Pricing Model Pre-Revenue

Ownership Public Benefit Corporation

Drug Design Engine

Provider Isomorphic Labsisomorphiclabs.com$2.8B raised · Series B

Founded 2021

Sells To Enterprise

Pricing Model Licensing

Ownership Venture-backed private company

FutureHouse

Provider FutureHousefuturehouse.org

Founded 2023

Sells To —

Pricing Model —

Ownership —

Similar Products & Services

  • Pharma.ai logo

    Pharma.ai